Società Edwards Lifesciences Corporation BOERSE MUENCHEN
Azioni
EWL
US28176E1082
Attrezzatura medica
Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
79,01 EUR | -0,42% | -1,65% | +13,51% |
Attività
- valvole cardiache e prodotti chirurgici (67,9%);
- sistemi di monitoraggio emodinamico (15,5%);
- altro (16,6%): cateteri a palloncino, impianti artificiali, ecc.
Le vendite nette sono distribuite geograficamente come segue: Stati Uniti (58,4%), Europa (22,2%), Giappone (7,6%) e altro (11,8%).
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta | ||
---|---|---|---|---|---|---|---|
Transcatheter Mitral and Tricuspid Therapies
64,6
%
| 3 518 | 65,4 % | 116 | 2,2 % | 3 880 | 64,6 % | +3.241,77% |
Surgical Heart Valve Therapy
16,6
%
| 893 | 16,6 % | 999 | 16,6 % | +11,89% | ||
Critical Care
15,5
%
| 855 | 15,9 % | 928 | 15,5 % | +8,55% | ||
Transcatheter Mitral and Tricuspid Therapies
3,3
%
| 3 518 | 65,4 % | 116 | 2,2 % | 198 | 3,3 % | +70,20% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
58,4
%
| 3 133 | 58,2 % | 3 509 | 58,4 % | +12,01% |
Europe
22,2
%
| 1 175 | 21,8 % | 1 335 | 22,2 % | +13,59% |
Rest of World
11,8
%
| 601 | 11,2 % | 709 | 11,8 % | +17,92% |
Japan
7,5
%
| 474 | 8,8 % | 452 | 7,5 % | -4,48% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 56 | 01/01/15 | |
Chairman | 71 | 01/01/00 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 01/01/14 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/19 |
Investor Relations Contact | - | - | |
Linda Park
LAW | General Counsel | 46 | - |
Corporate Officer/Principal | 66 | 01/07/17 | |
Tammy Perry
PRN | Corporate Officer/Principal | - | 01/07/11 |
Donald Bobo
PRN | Corporate Officer/Principal | 62 | 01/01/95 |
Gary I. Sorsher
LAW | General Counsel | 59 | 01/01/15 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 05/07/16 |
Director/Board Member | 67 | 13/11/14 | |
Steven Loranger
BRD | Director/Board Member | 72 | 16/03/16 |
Chairman | 71 | 01/01/00 | |
Paul LaViolette
BRD | Director/Board Member | 66 | 13/07/20 |
Kieran Gallahue
BRD | Director/Board Member | 60 | 10/02/15 |
Martha Marsh
BRD | Director/Board Member | 75 | 22/10/15 |
Ramona Sequeira
BRD | Director/Board Member | 58 | 07/05/20 |
Chief Executive Officer | 56 | 01/01/15 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 652 000 000 | 597 241 946 ( 91,60 %) | 49 400 000 ( 7,577 %) | 91,60 % |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
Edwards Lifesciences World Trade Corp.
Edwards Lifesciences World Trade Corp. Medical SpecialtiesHealth Technology Part of Edwards Lifesciences Corp., Edwards Lifesciences World Trade Corp. is an American company. The private company is located in the US. |
Medical Specialties
|
Edwards Lifesciences Technology SARL
| |
Edwards Lifesciences (India) Pvt Ltd.
Edwards Lifesciences (India) Pvt Ltd. Medical SpecialtiesHealth Technology Part of Edwards Lifesciences Corp., Edwards Lifesciences (India) Pvt Ltd. is an Indian company that designs, develops, manufactures and markets products to treat late-stage cardiovascular disease. The private company is based in Mumbai, India. |
Medical Specialties
|
Edwards Lifesciences AG
Edwards Lifesciences AG Medical SpecialtiesHealth Technology Part of Edwards Lifesciences Corp., Edwards Lifesciences AG is a Swiss company that manufactures and distributes healthcare equipment. The private company is based in Nyon, Switzerland. |
Medical Specialties
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+8,06% | 218 Mrd | |
+6,94% | 184 Mrd | |
+13,54% | 135 Mrd | |
-0,27% | 62,38 Mrd | |
+7,76% | 50,9 Mrd | |
+1,14% | 40,87 Mrd | |
+3,21% | 36,28 Mrd | |
+26,11% | 31,88 Mrd | |
+17,81% | 24,39 Mrd |
- Borsa valori
- Azioni
- Azione EW
- Azione EWL
- Società Edwards Lifesciences Corporation